indinavir การใช้
- Crixivan ( indinavir )-- Merck & Co.
- This group's combination therapy included another protease inhibitor, indinavir.
- Indinavir inhibits urinary nitrous oxide production and may inhibit nitric oxide production.
- Merck & Co . is asking for approval to market indinavir.
- A second group took AZT and 3TC and a third took indinavir alone.
- In addition, cost may be prohibitive for many people for indinavir and similar drugs.
- The first, developed by Merck & Co ., is called indinavir.
- Merck Co . manufactures indinavir as Crixivan.
- Indinavir impairs endothelial function in healthy HIV-negative men and may accelerate atherosclerotic disease.
- Four months later, two other protease inhibitors, ritonavir and indinavir, were approved.
- Indinavir, which is a peptidomimetic hydroxyethylene HIV protease inhibitor, reached the market in 1996.
- In fact, the FDA has approved indinavir and two other protease inhibitors for the treatment of AIDS.
- The pediatric formulation Merck concocted for indinavir was so bitter in early studies that many children refused it.
- Crixivan, known chemically as indinavir, is taken preferably on an empty stomach and with lots of water.
- And 24 out of 26 patients combining indinavir with two other drugs ( AZT and 3TC ) achieved that result.
- Two trials are part of programs that led to government approval of the protease inhibitors Indinavir and Ritonavir in February.
- In the French study, participants took triple drug therapy ( AZT, 3TC and indinavir ) for three months.
- Its protease inhibitor, indinavir sulphate ( Crixivan ), began phase III trials in 3, 000 patients this spring.
- Kidney stones appear to be the main hazard from indinavir, appearing in about 2 percent to 3 percent of patients.
- Emini said one patient who had received indinavir alone had been healthy and apparently free of the virus for two years.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3